首页> 美国卫生研究院文献>other >Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumors
【2h】

Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumors

机译:多通道成像可量化肿瘤中四类药代动力学分布

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Low and heterogeneous delivery of drugs and imaging agents to tumors results in decreased efficacy and poor imaging results. Systemic delivery involves a complex interplay of drug properties and physiological factors, and heterogeneity in the tumor microenvironment makes predicting and overcoming these limitations exceptionally difficult. Theoretical models have indicated that there are four different classes of pharmacokinetic behavior in tissue, depending on the fundamental steps in distribution. In order to study these limiting behaviors, we used multichannel fluorescence microscopy and stitching of high-resolution images to examine the distribution of four agents in the same tumor microenvironment. A validated generic partial differential equation model with a graphical user interface was used to select fluorescent agents exhibiting these four classes of behavior, and the imaging results agreed with predictions. BODIPY-FL exhibited higher concentrations in tissue with high blood flow, cetuximab gave perivascular distribution limited by permeability, high plasma protein and target binding resulted in diffusion-limited distribution for Hoechst 33342, and Integrisense 680 was limited by the number of binding sites in the tissue. Together, the probes and simulations can be used to investigate distribution in other tumor models, predict tumor drug distribution profiles, and design and interpret in vivo experiments.
机译:药物和显像剂向肿瘤的低度和异质递送导致功效降低和显像效果差。全身递送涉及药物特性和生理因素的复杂相互作用,并且肿瘤微环境中的异质性使得预测和克服这些局限性异常困难。理论模型表明,根据分布的基本步骤,组织中有四种不同的药代动力学行为。为了研究这些限制性行为,我们使用多通道荧光显微镜和高分辨率图像拼接来检查四种药物在同一肿瘤微环境中的分布。经过验证的具有图形用户界面的通用偏微分方程模型用于选择表现出这四类行为的荧光剂,并且成像结果与预测相符。 BODIPY-FL在高血流量的组织中表现出较高的浓度,西妥昔单抗的血管周分布受到通透性的限制,血浆蛋白高,靶标结合导致Hoechst 33342的扩散受限分布,而Integrisense 680受到血管中结合位点数量的限制。组织。探针和模拟可以一起用于研究其他肿瘤模型中的分布,预测肿瘤药物分布图以及设计和解释体内实验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号